Resolving shortages of prescription drugs: the case for public-private collaboration
The recent IJHPR article by Schwartzberg and colleagues presents new data on the growing problem of prescription drug shortages. Resolving shortages typically involves many participants: government, industry, physicians and healthcare facilities. Israel has a strong record of informal collaboration...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424491/ https://www.ncbi.nlm.nih.gov/pubmed/28496968 http://dx.doi.org/10.1186/s13584-017-0152-5 |
_version_ | 1783235147959631872 |
---|---|
author | Katz, Eric Efraim |
author_facet | Katz, Eric Efraim |
author_sort | Katz, Eric Efraim |
collection | PubMed |
description | The recent IJHPR article by Schwartzberg and colleagues presents new data on the growing problem of prescription drug shortages. Resolving shortages typically involves many participants: government, industry, physicians and healthcare facilities. Israel has a strong record of informal collaboration that can fix drug shortages quickly. The success of Israel’s informal collaborations, as well as its formal partnerships, deserves broader recognition at home and more attention from the international community. |
format | Online Article Text |
id | pubmed-5424491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54244912017-05-11 Resolving shortages of prescription drugs: the case for public-private collaboration Katz, Eric Efraim Isr J Health Policy Res Commentary The recent IJHPR article by Schwartzberg and colleagues presents new data on the growing problem of prescription drug shortages. Resolving shortages typically involves many participants: government, industry, physicians and healthcare facilities. Israel has a strong record of informal collaboration that can fix drug shortages quickly. The success of Israel’s informal collaborations, as well as its formal partnerships, deserves broader recognition at home and more attention from the international community. BioMed Central 2017-05-10 /pmc/articles/PMC5424491/ /pubmed/28496968 http://dx.doi.org/10.1186/s13584-017-0152-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Katz, Eric Efraim Resolving shortages of prescription drugs: the case for public-private collaboration |
title | Resolving shortages of prescription drugs: the case for public-private collaboration |
title_full | Resolving shortages of prescription drugs: the case for public-private collaboration |
title_fullStr | Resolving shortages of prescription drugs: the case for public-private collaboration |
title_full_unstemmed | Resolving shortages of prescription drugs: the case for public-private collaboration |
title_short | Resolving shortages of prescription drugs: the case for public-private collaboration |
title_sort | resolving shortages of prescription drugs: the case for public-private collaboration |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424491/ https://www.ncbi.nlm.nih.gov/pubmed/28496968 http://dx.doi.org/10.1186/s13584-017-0152-5 |
work_keys_str_mv | AT katzericefraim resolvingshortagesofprescriptiondrugsthecaseforpublicprivatecollaboration |